Pathogenic Exosomes in COPD
Overview
Organization: National Heart, Lung, and Blood Institute
Start Date: 04/2023
End Date: Ongoing
Primary Goal: Goal 4: Increase and sustain research to better understand the prevention, pathogenesis, diagnosis, treatment, and management of COPD.
Secondary Goal(s):
Objective(s):
- Help expand, coordinate, and optimize COPD research efforts
Collaboration: University of Alabama at Birmingham
Activity Type: Research
Activity Description
This project describes a new extracellular entity, the pathogen exosome. In diseases such as COPD this type of exosome drives chronic inflammation, tissue damage, and cell death. A complete understanding of the pathogenic exosome may lead to new diagnostics and therapeutics for chronic inflammatory diseases such as COPD.Audience
General Audience: Researchers
Focused Audience: n/a
Program Reach: National
Type of Area: N/A
Setting: Workplace
Cost and Funding Sources
It was funded through the National Heart, Lung, and Blood Institute and funds to be allotted to grantees.Impact Analysis
Results of their programs are in progress.Advice or Lessons Learned
In process.Related Links
Contact Information
National Heart, Lung, and Blood Institute
Program Analyst
Bethesda
Maryland